Ilana Graetz

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 18

Top Venues

JCO oncology practice

Journal of the National Cancer Institute

JNCI cancer spectrum

Journal of general internal medicine

Emory University School of Public Health

University of California Berkeley (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Emory University School of Public Health Jan 01 2019

United States

Associate Professor :: Health Policy and Management

Education History

University of California Berkeley Aug 01 2007 - Dec 01 2012

United States

PHD :: School of Public Health - Health Policy

Publications

Xin Hu, Ian McCarthy, K Robin Yabroff, Wen You, Joseph Lipscomb, Ilana Graetz
Association Between Medicare Site-Based Payment Policy, Physician Practice Characteristics, and Vertical Integration Among Oncologists. JCO oncology practice (2024)
Ilana Graetz, Samuel Hernandez, Sara Arshad, Kristina Byers, Jane Meisel, Gelareh Sadigh, Elizabeth A Sakach, Keerthi Gogineni, Mylin A Torres
Leveraging Mobile Health to Improve Capecitabine Adherence Among Women With Breast Cancer: A Pilot Randomized Controlled Trial. JCO oncology practice (2024)
Ilana Graetz, Jie Huang, Anjali Gopalan, Emilie Muelly, Andrea Millman, Mary E Reed
Primary Care Telemedicine and Care Continuity: Implications for Timeliness and Short-term Follow-up Healthcare. Journal of general internal medicine (2024)
Ilana Graetz, Samuel Hernandez, Sara Arshad, Kristina Byers, Jane Meisel, Gelareh Sadigh, Elizabeth A Sakach, Keerthi Gogineni, Mylin A Torres
Leveraging Mobile Health to Improve Capecitabine Adherence Among Women With Breast Cancer: A Pilot Randomized Controlled Trial. JCO oncology practice (2024)
Ilana Graetz, Samuel Hernandez, Sara Arshad, Kristina Byers, Jane Meisel, Gelareh Sadigh, Elizabeth A Sakach, Keerthi Gogineni, Mylin A Torres
Leveraging Mobile Health to Improve Capecitabine Adherence Among Women With Breast Cancer: A Pilot Randomized Controlled Trial. JCO oncology practice (2024)
Xin Hu, Joseph Lipscomb, Changchuan Jiang, Ilana Graetz
Vertical integration of oncologists and cancer outcomes and costs in metastatic castration-resistant prostate cancer. Journal of the National Cancer Institute 115 (3) (2023)
Ilana Graetz, Xin Hu, Xu Ji, Martha Wetzel, Courtney R Yarbrough
The effect of cancer exemption in mandatory-access prescription drug monitoring programs among oncologists. JNCI cancer spectrum 7 (2) (2023)
Xin Hu, Joseph Lipscomb, Changchuan Jiang, Ilana Graetz
Vertical integration of oncologists and cancer outcomes and costs in metastatic castration-resistant prostate cancer. Journal of the National Cancer Institute 115 (3) (2023)
Mary E Reed, Jie Huang, Madeline J Somers, Loretta Hsueh, Ilana Graetz, Andrea Millman, Emilie Muelly, Anjali Gopalan
Telemedicine Versus In-Person Primary Care: Treatment and Follow-up Visits. Annals of internal medicine 176 (10) (2023)
Ilana Graetz, Xin Hu, Xu Ji, Martha Wetzel, Courtney R Yarbrough
The effect of cancer exemption in mandatory-access prescription drug monitoring programs among oncologists. JNCI cancer spectrum 7 (2) (2023)
Ilana Graetz, Xin Hu, Xu Ji, Martha Wetzel, Courtney R Yarbrough
The effect of cancer exemption in mandatory-access prescription drug monitoring programs among oncologists. JNCI cancer spectrum 7 (2) (2023)
Xin Hu, Joseph Lipscomb, Changchuan Jiang, Ilana Graetz
Vertical integration of oncologists and cancer outcomes and costs in metastatic castration-resistant prostate cancer. Journal of the National Cancer Institute 115 (3) (2023)
Jie Huang, Ilana Graetz, Andrea Millman, Anjali Gopalan, Catherine Lee, Emilie Muelly, Mary E Reed
Primary care telemedicine during the COVID-19 pandemic: patient's choice of video versus telephone visit. JAMIA open 5 (1) (2022)
Ilana Graetz, Xin Hu, Andrea N Curry, Andrew Robles, Gregory A Vidal, Florian Scotté
Mobile application to support oncology patients during treatment on patient outcomes: Evidence from a randomized controlled trial. Cancer medicine (2022)
Xin Hu, Cameron M Kaplan, Michelle Y Martin, Mark S Walker, Edward Stepanski, Florian Scotté, Gregory A Vidal, Ilana Graetz
Race differences in patient-reported symptoms during chemotherapy among women with early-stage hormone receptor positive breast cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2022)
Janeane N Anderson, Rebecca A Krukowski, Andrew J Paladino, J Carolyn Graff, Lee Schwartzberg, Andrea N Curry, Gregory A Vidal, Tameka N Jones, Teresa M Waters, Ilana Graetz
THRIVE intervention development: using participatory action research principles to guide a mHealth app-based intervention to improve oncology care. Journal of hospital management and health policy 5 (2021)
Andrew J Paladino, Janeane N Anderson, Rebecca A Krukowski, Teresa Waters, Mehmet Kocak, Carolyn Graff, Ryan Blue, Tameka N Jones, Joanne Buzaglo, Gregory Vidal, Lee Schwartzberg, Ilana Graetz
THRIVE study protocol: a randomized controlled trial evaluating a web-based app and tailored messages to improve adherence to adjuvant endocrine therapy among women with breast cancer. BMC health services research 19 (1) (2019)
Ilana Graetz, Caitlin N McKillop, Edward Stepanski, Gregory A Vidal, Janeane N Anderson, Lee S Schwartzberg
Use of a web-based app to improve breast cancer symptom management and adherence for aromatase inhibitors: a randomized controlled feasibility trial. Journal of cancer survivorship : research and practice 12 (4) (2018)

Ilana Graetz.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ilana Graetz